St. Jude Children's Research Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
St. Jude Children's Research Hospital brings 6 presentations to ASH 2026 in New Orleans, and exhibits at Booth 2824. Its program centres on childhood blood cancers and bone marrow failure, from CAR T for pediatric AML to the inherited genetics of pediatric MDS. It also covers bringing newborn sickle cell screening to rural areas and lower-income countries.
| Organization | ASH 2026 Attendance |
|---|---|
St. Jude Children's Research Hospital Memphis, TN | |
Pediatric research hospital in Memphis focused on childhood cancer, combining laboratory research, clinical trials, patient care and training. | Booth Exhibiting at Booth 2824 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00pm–10:00pm Overcoming the Challenges of Managing Adolescents and Young Adults With Ph-Negative Acute Lymphoblastic Leukemia Pediatric-style regimens, asparaginase, immunotherapy, and CAR-T for teens and young adults with acute lymphoblastic leukemia, plus their psychosocial needs. Talk Regulation of HSCs by the Adaptive Immune System How T cells and other adaptive immune cells recognize and clear mutant blood stem cells, and harnessing this to prevent premalignant clonal expansion. Talk Escape Clones in Immune Mediated BMF How blood stem cells in aplastic anemia dodge attacking T cells by disabling a tissue-type gene, repeatedly and independently, years before diagnosis. Talk Metabolic Switches Underpin Erythropoiesis A link between glutamine handling and heme production in maturing red cells, and how losing that detoxifying step goes wrong in beta-thalassemia. Talk Dissecting the Functional Consequence of Non-Coding Variants How CRISPR screens and single-cell methods show the way non-coding DNA variants alter gene regulation in acute lymphoblastic leukemia. Talk CAR T-Cell Therapy in Pediatric AML: Current Limitations and Emerging Opportunities Barriers facing CAR-T therapy in childhood acute myeloid leukemia and how multi-target designs and tumor-environment combinations might overcome them. Session Innovations in the Treatment of Pediatric AML How gene-fusion biology in childhood acute myeloid leukemia is shaping targeted and antibody-drug conjugate treatments beyond standard chemotherapy. Talk Integrating Newborn Screening for SCD by CONSA, St Jude's Global Hematology and Ministries of Health into PEN-Plus in LMICs and Rural Settings Adding newborn sickle cell disease screening to chronic disease care in low-resource and rural regions, drawing on a Mozambique case study. |
Instantly find 20 buyers from St. Jude Children's Research Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction